251 related articles for article (PubMed ID: 15164415)
1. A novel PCR approach for prenatal detection of the common NEMO rearrangement in incontinentia pigmenti.
Steffann J; Raclin V; Smahi A; Woffendin H; Munnich A; Kenwrick SJ; Grebille AG; Benachi A; Dumez Y; Bonnefont JP; Hadj-Rabia S
Prenat Diagn; 2004 May; 24(5):384-8. PubMed ID: 15164415
[TBL] [Abstract][Full Text] [Related]
2. De novo NEMO gene deletion (delta4-10)--a cause of incontinentia pigmenti in a female infant: a case report.
Culić V; Gabrić D; Puizina-Ivić N; Rozman K; Peterlin B; Pavelić J
Coll Antropol; 2008 Dec; 32(4):1259-62. PubMed ID: 19149237
[TBL] [Abstract][Full Text] [Related]
3. [An incontinentia pigmenti family with deletion in both NEMO gene and pseudogene DeltaNEMO].
Zhang G; Shi H; Du X; Shao M; Zhou Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):573-5. PubMed ID: 18841575
[TBL] [Abstract][Full Text] [Related]
4. Clinical diagnosis of incontinentia pigmenti in a cohort of male patients.
Fusco F; Fimiani G; Tadini G; Michele D; Ursini MV
J Am Acad Dermatol; 2007 Feb; 56(2):264-7. PubMed ID: 17224368
[TBL] [Abstract][Full Text] [Related]
5. [Incontinentia pigmenti. Four patients with different clinical manifestations].
Llano-Rivas I; Soler-Sánchez T; Málaga-Diéguez I; Fernández-Toral J
An Pediatr (Barc); 2012 Mar; 76(3):156-60. PubMed ID: 22036144
[TBL] [Abstract][Full Text] [Related]
6. [Variable clinical expression of familial Incontinentia Pigmenti syndrome - presentation of three cases].
Kutkowska-Kaźmierczak A; Obersztyn E; Bonnefont JP; Rosińska-Borkowska D; Mazurczak T; Sobczyńska-Tomaszewska A; Mazurczak T
Med Wieku Rozwoj; 2008; 12(3):748-53. PubMed ID: 19305025
[TBL] [Abstract][Full Text] [Related]
7. NEMO gene rearrangement (exon 4-10 deletion) and genotype-phenotype relationship in Japanese patients with incontinentia pigmenti and review of published work in Japanese patients.
Okita M; Nakanishi G; Fujimoto N; Shiomi M; Yamada T; Wataya-Kaneda M; Takijiri C; Yokoyama Y; Sunohara A; Tanaka T
J Dermatol; 2013 Apr; 40(4):272-6. PubMed ID: 23398170
[TBL] [Abstract][Full Text] [Related]
8. Linkage analysis in 16 families with incontinentia pigmenti.
Jouet M; Stewart H; Landy S; Yates J; Yong SL; Harris A; Garret C; Hatchwell E; Read A; Donnai D; Kenwrick S
Eur J Hum Genet; 1997; 5(3):168-70. PubMed ID: 9272741
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular analysis of NF-kappaB essential modulator in Chinese incontinentia pigmenti patients.
Zou CC; Zhao ZY
Int J Dermatol; 2007 Oct; 46(10):1017-22. PubMed ID: 17910706
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in the genetics of incontinentia pigmenti (Bloch-Sulzberger syndrome).
Shastry BS
J Hum Genet; 2000; 45(6):323-6. PubMed ID: 11185738
[TBL] [Abstract][Full Text] [Related]
11. Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKgamma dene deletion.
Bardaro T; Falco G; Sparago A; Mercadante V; Gean Molins E; Tarantino E; Ursini MV; D'Urso M
Hum Mutat; 2003 Jan; 21(1):8-11. PubMed ID: 12497627
[TBL] [Abstract][Full Text] [Related]
12. NEMO gene mutations in Chinese patients with incontinentia pigmenti.
Hsiao PF; Lin SP; Chiang SS; Wu YH; Chen HC; Lin YC
J Formos Med Assoc; 2010 Mar; 109(3):192-200. PubMed ID: 20434027
[TBL] [Abstract][Full Text] [Related]
13. [Proposal for a protocol for the staging of incontinentia pigmenti in pediatric age].
Portaleone D; Taroni F; Micheli S; Moioli M; Pedrazzini A; Cognizzoli P; Carnelli V
Minerva Pediatr; 2007 Jun; 59(3):255-65. PubMed ID: 17519871
[TBL] [Abstract][Full Text] [Related]
14. [Incontinentia pigmenti. A rare disease with many symptoms].
Holmström G; Bergendal B; Hallberg G; Marcus S; Hallén A; Dahl N
Lakartidningen; 2002 Mar; 99(12):1345-50. PubMed ID: 11998169
[TBL] [Abstract][Full Text] [Related]
15. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
16. [Incontinentia pigmenti: three new cases that demonstrate it is not only a matter of women].
Feito-Rodríguez M; García-Macarrón J; Bravo-Burguillos ER; Vera-Casaño A; de Lucas-Laguna R
Actas Dermosifiliogr; 2007 Mar; 98(2):112-5. PubMed ID: 17397599
[TBL] [Abstract][Full Text] [Related]
17. The common NF-κB essential modulator (NEMO) gene rearrangement in Korean patients with incontinentia pigmenti.
Song MJ; Chae JH; Park EA; Ki CS
J Korean Med Sci; 2010 Oct; 25(10):1513-7. PubMed ID: 20890435
[TBL] [Abstract][Full Text] [Related]
18. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.
Smahi A; Courtois G; Vabres P; Yamaoka S; Heuertz S; Munnich A; Israël A; Heiss NS; Klauck SM; Kioschis P; Wiemann S; Poustka A; Esposito T; Bardaro T; Gianfrancesco F; Ciccodicola A; D'Urso M; Woffendin H; Jakins T; Donnai D; Stewart H; Kenwrick SJ; Aradhya S; Yamagata T; Levy M; Lewis RA; Nelson DL
Nature; 2000 May; 405(6785):466-72. PubMed ID: 10839543
[TBL] [Abstract][Full Text] [Related]
19. [NEMO Delta 4-10 deletion of NEMO gene in Chinese incontinentia pigmenti cases].
Li L; Song GW; DU JB; Liu JR; Xu FS; Liu XY; Zhang T
Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):89-92. PubMed ID: 15833158
[TBL] [Abstract][Full Text] [Related]
20. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.
Nenci A; Huth M; Funteh A; Schmidt-Supprian M; Bloch W; Metzger D; Chambon P; Rajewsky K; Krieg T; Haase I; Pasparakis M
Hum Mol Genet; 2006 Feb; 15(4):531-42. PubMed ID: 16399796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
